Apollo Health Ventures — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
Refoxy is a science-driven company focused on drug discovery, medicinal chemistry, and bioinformatics.
BiotechDeep TechHealthtechLongevity
Victor Bustos(Co-Founder & CEO)inWolfgang Link(Scientific Co-founder & Advisor)inAndrew Pierce(Chief Science Officer)in
Co-investorsKorify CapitalBoehringer Ingelheim Venture FundHTGF
Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.
BiotechHealthtechLongevityMedical DevicesLausanne, CH
Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)
Co-investors+ND CapitalDolby Family VenturesLevensohn Venture Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Booster Therapeutics
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








